fda glp-1 warning letters news issues 30 to online compounders FDA warnings against compounded GLP-1s

On the same sheet pan, roast zucchini, bell peppers, and asparagus with a light mist of olive oil

T2D: type 2 diabetes

To probe the translational potential of GLP-1MK-801, we assessed whether the differentially expressed genes regulated in response to treatment overlapped with genes located in obesity-associated GWAS loci (Fig

My goal is to help patients find a treatment plan that is realistic, medically appropriate, and sustainable long term. Dr

In light of increasing GLP-1RA use and these significant knowledge gaps, we conducted a structured literature search in March 2024 using the terms GLP-1 receptor agonists AND inflammatory bowel disease OR ulcerative colitis OR Crohns disease. This narrative review is, to our knowledge, the first to comprehensively explore the pathophysiological rationale, pre-clinical evidence, and clinical considerations of GLP-1RA use in IBD

On one hand, the cardiovascular protection afforded by SGLT2is seems to result from their beneficial hemodynamic effects, including improvement in ventricular preload (secondary to natriuresis and osmotic diuresis) and afterload (through blood pressure reduction), but also from improvement of cardiac metabolism (through the switch from utilization of glucose to ketones), inhibition of the myocardial Na + /H + exchanger, reduction of cardiac fibrosis and necrosis, reduction of proinflammatory adipokines derived from epicardial and perivascular fat, and stimulation of erythropoiesis (which can facilitate the release of oxygen to ischemic tissues) [1, 4, 14,15,16]